1h Free Analyst Time
The Deep Brain Stimulation in Parkinson’s Disease Market grew from USD 1.07 billion in 2023 to USD 1.23 billion in 2024. It is expected to continue growing at a CAGR of 15.40%, reaching USD 2.93 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Deep Brain Stimulation (DBS) is an advanced therapeutic intervention used in the treatment of Parkinson’s Disease, where electrodes are surgically implanted in the brain to deliver electrical impulses, regulating abnormal impulses. The necessity for DBS arises due to its ability to enhance the quality of life in patients by mitigating symptoms like tremors, rigidity, and bradykinesia, especially when medication ceases to be effective. The key applications of DBS involve addressing movement disorders, with an increasing focus on psychiatric indications. It finds end-use primarily in hospitals, specialized neurological clinics, and academic & research institutes, aiming to extend its reach due to an ageing global population and the rising prevalence of neurological disorders. Recent market insights indicate robust growth due to technological advancements and increasing acceptance of these surgical procedures, with North America and Europe leading the charge owing to better healthcare infrastructure and insurance support. The potential opportunities lie in expanding its application scope, integrating with smart technologies for precision, and exploring non-motor symptom management. However, challenges such as high costs, lack of awareness, and potential side effects remain barriers, alongside stringent regulatory pathways. Companies can focus on patient education and healthcare provider training as strategies to mitigate these challenges. Innovation opportunities abound in miniaturization of devices, improving battery life, and developing adaptive stimulation algorithms. Collaborations between medical device manufacturers, neuroscientists, and tech companies could yield breakthroughs in DBS technologies that enhance patient outcomes. The market is evolving towards more personalized and minimally invasive techniques, with a pronounced trend towards continuous monitoring and real-time data analytics in patient management. To thrive, businesses should leverage AI-driven platforms and wearable technology integrations to create patient-centric and outcome-based therapeutic solutions.
Understanding Market Dynamics in the Deep Brain Stimulation in Parkinson’s Disease Market
The Deep Brain Stimulation in Parkinson’s Disease Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Increasing incidences of neurological diseases
- Rapidly aging population, leading to risk and high prevalence of neurological disorders
- Rising popularity of minimally invasive procedures
- Market Restraints
- Complex regulatory framework
- Market Opportunities
- Increasing technological advancement in devices
- Surge in neurological R&D
- Market Challenges
- Complications of deep brain stimulation surgery
Exploring Porter’s Five Forces for the Deep Brain Stimulation in Parkinson’s Disease Market
Porter’s Five Forces framework further strengthens the insights of the Deep Brain Stimulation in Parkinson’s Disease Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Deep Brain Stimulation in Parkinson’s Disease Market
External macro-environmental factors deeply influence the performance of the Deep Brain Stimulation in Parkinson’s Disease Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Deep Brain Stimulation in Parkinson’s Disease Market
The Deep Brain Stimulation in Parkinson’s Disease Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Deep Brain Stimulation in Parkinson’s Disease Market
The Deep Brain Stimulation in Parkinson’s Disease Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Deep Brain Stimulation in Parkinson’s Disease Market
The Deep Brain Stimulation in Parkinson’s Disease Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Deep Brain Stimulation in Parkinson’s Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Beijing Pins Medical Co.,Ltd., Boston Scientific Corporation, Functional Neuromodulation Ltd., General Electric Co., Medtronic PLC, MicroTransponder Inc., Neuronetics Inc., NeuroPace Inc., NeuroSigma, Inc., Nexstim Oy, Renishaw PLC, Siemens AG, St. Jude Medical, Inc., and Synapse Biomedical Inc..Market Segmentation & Coverage
This research report categorizes the Deep Brain Stimulation in Parkinson’s Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Dual Channel
- Single Channel
- End-User
- Ambulatory Surgical Centers
- Hospitals
- Neurology Clinics
- Research Centers
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Deep Brain Stimulation in Parkinson’s Disease Market, by Product
7. Deep Brain Stimulation in Parkinson’s Disease Market, by End-User
8. Americas Deep Brain Stimulation in Parkinson’s Disease Market
9. Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market
10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market
11. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the Deep Brain Stimulation in Parkinson’s Disease Market, which are profiled in this report, include:- Abbott Laboratories
- Aleva Neurotherapeutics SA
- Beijing Pins Medical Co.,Ltd.
- Boston Scientific Corporation
- Functional Neuromodulation Ltd.
- General Electric Co.
- Medtronic PLC
- MicroTransponder Inc.
- Neuronetics Inc.
- NeuroPace Inc.
- NeuroSigma, Inc.
- Nexstim Oy
- Renishaw PLC
- Siemens AG
- St. Jude Medical, Inc.
- Synapse Biomedical Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.23 Billion |
| Forecasted Market Value ( USD | $ 2.93 Billion |
| Compound Annual Growth Rate | 15.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
